Neoplasms were reported in 3 patients during GH treatment [osteochondroma (n=1), gastric carcinoid tumor (n=1) and malignant melanoma after optic glioma (n=1)]. This evidence concerns the gene GH1 and gastric neuroendocrine tumor G1.